With respect to selective vulnerability of transmitter systems, the marked degeneration of cholinergic neurons in the basal forebrain has received considerable attention 26'28'29. However, several features of DAT cannot be explained l:y the cholinergic hypothesis. Notably, the regional distribution of cortical cholinergic innervation from basal forebrain does not coincide with the cortical areas manifesting the greatest plaque and tangle density 3°. Lesions to the cholinergic basal forebrain neurons in rats and primates have not been shown to produce cortical plaques or tangles. In addition, basal forebrain lesions do not produce the somatostatin 31 and catecholamine 32 deficits seen in DAT. Finally, the signs and symptoms of cortical disconnection in DAT are difficult to explain solely on the basis of loss of cortical cholinergic afferents. Thus, while pathology of the ascending cholinergic system is undoubtedly present in DAT, it appears that other neurochemical systems must be involved in the pathophysiology of this disease.
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Recently, the excitatory amino acid neurotransmitter, glutamate, has been implicated in learning and memory 33. A subtype of glutamate receptor, the N-methyI-D-aspartate (NMDA) receptor, appears to be particularly important in these processes. In hippocampus, NMDA-receptor antagonists inhibit synaptic transmission in dentate gyrus 3", block the development of long-term potentiation (LTP) in vitro (a model of memory formation) 3s, and impair spatial discrimination learning and LTP in vivo 36. NMDAreceptor-mediated excitation has also been observed in cerebral cortex 37. The NMDA receptor is coupled to a voltage-sensitive cation channel that is gated by Mg 2+ (Ref. 38) and blocked by the dissociative anaesthetics ketamine and phencyclidine (PCP) 39. Both Mg a÷ (Ref. 40 ) and the dissociative anaesthetics inhibit the excitatory actions of NMDA 41 and the latter block the formation of LTP 42. Furthermore, anaesthesia induced with dissociative anaesthetics has been reported to produce retrograde and anterograde amnesia of events surrounding the surgical procedure 43. Thus, impaired glutamate receptor function may be associated with learning and memory impairments.
In this regard, glutamate receptors, particularly the NMDA subtype, have been shown to be decreased in the neocortex of DAT patients compared to agematched controls or Huntington s disease patients :°. The largest decreases are seen in the outer cortical layers and the CAI and CA2 regions of the hippocampus. In the cerebral cortex, total glutamate binding is decreased 35-40%, and NMDA receptor density is decreased approximately 60%. Decreases in quisqualate and NMDA receptor subtypes also are observed throughout the CAIICA2 region of the hippocampal formation, although changes in NMDA receptors are the most prominent, approaching 90% loss in stratum pyramidale 44. Muscarinic cholinergic, benzodiazepine and high-affinity GABA receptors are not significantly changed in these areas ~'45, suggesting that the decreased glutamate binding does not simply reflect cortical atrophy. Glutamate binding is also reduced in the subiculum of DAT brains 44. The subiculum is the primary source of hippocampal efferent fibers 46 and shows major pathology in DAT 8. It is likely that glutamatergic neurotransmission in cortex and hippocampal formation is severely disrupted. The profound loss of glutamate receptors in these regions may provide an explanation for the learning and memory deficits that are prominent in DAT.
Symptoms of cortical disconnection are also common in DAT. These symptoms might be due to the above-mentioned reduction of glutamate receptors as well as loss of afferent input. Corticocortical association fibers arise from presumptive glutamatergic pyramidal cells 47'48. Their axons terminate primarily in superficial and deep layers of other cortical regions, largely on spines of the apical and basal dendrites of other pyramidal cells 49. In DAT, cortical glutamate receptor loss is greatest in superficial and deep layers 2°. Senile plaques and neurofibrillary tangles are concentrated in zones of 50 51 association fiber termination ' as well as in layers where the cell bodies of these fibers originate 51.
